Strokes are a major cause of death and result in a drastic reduction in quality of life. Novel therapeutic strategies for patients suffering from stroke are thus required. Two possible strategies can ...

Algernon Pharmaceuticals’ AGNPF wholly-owned Algernon NeuroScience (AGN Neuro) successfully completed dosing the third and final cohort of its Phase 1 clinical study assessing an intravenous (IV) ...

The brain's ability to adapt and form new neural connections allows it to recover from injury and maintain cognitive function into old age. Neuroplasticity is the brain's ability to adapt and ...

A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...

The human brain generates up to 700 new neurons per day in the hippocampus alone, which raises the question: Can this capacity be intentionally enhanced? Neuroplasticity is no longer just a recovery ...

In a recent study published in the journal Neuropharmacology, researchers in Pisa, Italy, explored how gut microbiota can influence neuroplasticity. Neuroplasticity is the ability of neuronal circuits ...

Imagine your brain as a bustling city with millions of interconnected highways carrying information at lightning speed. Now picture what happens when a major earthquake hits, destroying some of those ...

In December of 1993, former World Boxing Champion John Famechon (who had sustained severe incapacitating brain injuries in August 1991) began a new, complex multi-movement therapy and rehabilitation ...

In this review, we have briefly highlighted recent progress in the development of new strategies for the treatment of damaged brains following a stroke, with a focus on neuroplasticity, endogenous ...